Articles dans des revues avec comité de lecture (158)
  1. 86. Neuzillet, Y., Guy, L., Long, J.-A., Zini, L., Chevreau, C., Duclos, B., Escudier, B., Gimel, P., Joly, F., Lang, H., Mejean, A., Oudard, S., & Roumeguere, T. (2011). Cas cliniques de cancer du rein des JOUM 2010. Progrès en urologie, 21 Suppl 2, S27-S33. doi:10.1016/S1166-7087(11)70006-9
  2. 87. Zlotta, A., Roumeguere, T., Kuk, C., Alkhateeb, S., Rorive, S., Lemy, A., van der Kwast, T. H., Fleshner, N. E., Jewett, M. A., Finelli, A., Schulman, C., Lotan, Y., Shariat, S. F., & Nortier, J. (2011). Select screening in a specific high-risk population of patients suggests a stage migration toward detection of non–muscle-invasive bladder cancer. European urology, 59, 1026-1031. doi:10.1016/j.eururo.2011.03.027
  3. 88. Henriet, B., & Roumeguere, T. (2011). Overview of Conservative Erectile Dysfunction Treatment. European urology, 6(1), 56-59.
  4. 89. JAYASWAL, A., Roumeguere, T., Broeders, E. N., Quackels, T., Rorive, S., Lemy, A., & Nortier, J. (2011). Tolerance and efficacy of intravesical BCG treatment in non muscle-invasive bladder carcinoma after renal transplantation. Journal of the American Society of Nephrology, 22.
  5. 90. Luce, S., De Breucker, S., Van Gossum, A., Demols, A., Mekinda Ngono, Z. L., Ena, G., Kentos, A., Nouwynck, C., Van Laethem, J.-L., Sokolow, Y., Simon, P., Roumeguere, T., Ghanooni, R., Bailly, B., Vervaet, C., Marchand, M., & Pepersack, T. (2011). Vulnerability scores amongst old cancer patients. Journal of geriatric oncology, 2(1), 26.
  6. 91. Luce, S., De Breucker, S., Van Gossum, A., Demols, A., Mekinda Ngono, Z. L., Ena, G., Kentos, A., Nouwynck, C., Van Laethem, J.-L., Sokolow, Y., Simon, P., Roumeguere, T., Ghanooni, R., Bailly, B., Vervaet, C., Marchand, M., & Pepersack, T. (2011). Correlates of vulnerability amongst old cancer patients. Journal of geriatric oncology, 2(1), 26.
  7. 92. Simon, P., Roumeguere, T., & Noël, J. C. (2010). Human papillomavirus infection in couples with female low-grade intraepithelial cervical lesion. European journal of obstetrics, gynecology, and reproductive biology, 153(1), 8-11. doi:10.1016/j.ejogrb.2010.05.024
  8. 93. Roumeguere, T., Zouaoui Boudjeltia, K., Babar, S., Nuyens, V., Rousseau, A., Van Antwerpen, P., Ducobu, J., Wespes, E., & Vanhaeverbeek, M. (2010). Effects of phosphodiesterase inhibitors on the inflammatory response of endothelial cells stimulated by myeloperoxidase-modified low-density lipoprotein or tumor necrosis factor alpha. European urology, 57(3), 522-528. doi:10.1016/j.eururo.2009.01.030
  9. 94. Rossi, M., & Roumeguere, T. (2010). Silodosin in the treatment of benign prostatic hyperplasia. Drug Design, Development and Therapy, 4, 291-297. doi:10.2147/DDDT.S10428
  10. 95. Lelubre, C., Zouaoui Boudjeltia, K., Van Antwerpen, P., Vanhaeverbeek, M., & Roumeguere, T. (2010). Phosphodiesterase Inhibitors in the Treatment of Inflammatory Disorders: A Narrative Review. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 9(2), 1-15.
  11. 96. Verheyden, B., Roumeguere, T., Bitton, A., Belger, M., & Schmitt, H. (2009). Effects of 12-month tadalafil therapy for erectile dysfunction on couple relationships: results from the DETECT study. Journal of Sexual Medicine, 6(12), 3458-3468. doi:10.1111/j.1743-6109.2009.01527.x
  12. 97. Roumeguere, T., Van Antwerpen, P., Zouaoui Boudjeltia, K., Vanhaeverbeek, M., & Wespes, E. (2009). Maladies cardiovasculaires, dysfonction érectile et myéloperoxydase. Angéiologie, 61(3), 88-92.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Suivant >>